Ladenburg Thalmann Financial Services’s Enanta Pharmaceuticals ENTA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1K	Hold	12	–	–	﹤0.01%	5184
2019 Q3	$1K	Sell	12 -27	-69%	-$2.01K	﹤0.01%	5099
2019 Q2	$3K	Buy	39 +12	+44%	+$1.08K	﹤0.01%	4862
2019 Q1	$3K	Sell	27 -47	-64%	-$4.22K	﹤0.01%	4816
2018 Q4	$5K	Buy	+74	New	+$5.67K	﹤0.01%	4579
2016 Q3	–	Sell	-849	Closed	-$18K	–	4793
2016 Q2	$18K	Sell	849 -43	-5%	-$1.13K	﹤0.01%	3407
2016 Q1	$26K	Buy	892 +162	+22%	+$4.51K	﹤0.01%	3060
2015 Q4	$24K	Sell	730 -200	-22%	-$6.52K	﹤0.01%	3083
2015 Q3	$33K	Buy	930 +17	+2%	+$730	﹤0.01%	2750
2015 Q2	$41K	Hold	913	–	–	﹤0.01%	2722
2015 Q1	$28K	Sell	913 -9,185	-91%	-$357K	﹤0.01%	2967
2014 Q4	$513K	Buy	10,098 +9,833	+3,711%	+$440K	0.01%	911
2014 Q3	$10K	Buy	+265	New	+$10.6K	﹤0.01%	3092

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ENTA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Enanta Pharmaceuticals (ENTA) position steady in Q4 2019 at 12 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5184.

Ladenburg Thalmann Financial Services first reported a position in ENTA in Q3 2014 and has held it in 13 quarters since. The position peaked at $513K in Q4 2014. 171 funds tracked by Wall St. Rank hold ENTA as of Q4 2019.

Ladenburg Thalmann Financial Services held 12 shares of Enanta Pharmaceuticals worth $1K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Enanta Pharmaceuticals share count unchanged in Q4 2019.
Enanta Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5184 holding.
Ladenburg Thalmann Financial Services first reported a position in Enanta Pharmaceuticals in Q3 2014 and has held it in 13 quarters since.
Ladenburg Thalmann Financial Services's Enanta Pharmaceuticals position peaked at $513K in Q4 2014.
171 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.